Zhou Y, D’Andrea VD, Shanmugam SP, et al. Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer. European urology. 2024. doi:10.1016/j.eururo.2024.03.013
Publications
Pineda S, Lee H, Ulloa-Navas MJ, et al. Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD. Cell. 2024. doi:10.1016/j.cell.2024.02.031
Kim H, Nzabarushimana E, Huttenhower C, Chan AT, Nguyen LH. Altered microbial transcription in long-term proton pump inhibitor usage: findings from a US cohort study. Gastroenterology. 2024. doi:10.1053/j.gastro.2024.03.026
Chen H, Liu D, Guo J, et al. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA. Nature biotechnology. 2024. doi:10.1038/s41587-024-02174-7
Liwag EMP, Wei X, Acosta N, et al. Depletion of lamins B1 and B2 promotes chromatin mobility and induces differential gene expression by a mesoscale-motion-dependent mechanism. Genome biology. 2024;25(1):77. doi:10.1186/s13059-024-03212-y
Miranda A, Shirley CA, Jenkins RW. Emerging roles of TBK1 in cancer immunobiology. Trends in cancer. 2024. doi:10.1016/j.trecan.2024.02.007
Mitchell W, Goeminne LJE, Tyshkovskiy A, et al. Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation. eLife. 2024;12. doi:10.7554/eLife.90579
Tiger YKR, Jain S, Barta SK, et al. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leukemia & lymphoma. 2024:1-10. doi:10.1080/10428194.2024.2329996
Li H, Marin M, Farhat MR. Exploring gene content with pangenome gene graphs. ArXiv. 2024.